share_log

Larimar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(6.0%),Janus Henderson Biotech Innovation Master Fund Ltd(6.0%)

Larimar Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Janus Henderson Group plc(6.0%),Janus Henderson Biotech Innovation Master Fund Ltd(6.0%)

美股sec公告 ·  02/13 17:38
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息